Similar articles

• [Immunology and immunotherapy of cerebral tumors. Current status].

  Trouillas P. Trouillas P. Rev Neurol (Paris). 1973 Jan;128(1):23-38. Rev Neurol (Paris). 1973. PMID: 4367367 French. No abstract available.
• [Immunological study of glioma. (2) Changes of immunological responses during treatment].

  Sobue H, Tanimura K, Terabayashi T, Minagawa M, Inoue K. Sobue H, et al. No To Shinkei. 1976 Jan;28(1):87-93. No To Shinkei. 1976. PMID: 194609 Japanese. No abstract available.
• [Antigen-specific immunotherapy as a component of combined therapy for malignant brain tumors].

  Ostanin AA, Tsentner MI, Khonina NA, Leplina OIu, Shevela EIa, Nikonov SD, Stupak VV, Chërnykh ER. Ostanin AA, et al. Vopr Onkol. 2003;49(2):170-5. Vopr Onkol. 2003. PMID: 12785199 Clinical Trial. Russian.
• [Immunotherapy of brain tumors].

  Takakura K, Watanabe T. Takakura K, et al. No Shinkei Geka. 1982 Dec;10(12):1245-54. No Shinkei Geka. 1982. PMID: 6188989 Review. Japanese. No abstract available.
• Proceedings: Immunological investigations on human brain tumor patients.

  Mahaley MS Jr. Mahaley MS Jr. Proc Natl Cancer Conf. 1972;7:811-5. Proc Natl Cancer Conf. 1972. PMID: 4358071 Review. No abstract available.